Why the study?
Is candesartan cilexetil a safe therapeutic option for early antihypertensive therapy in patients with cerebral and myocardial ischemia?
Population
Patients with cerebral and myocardial ischemia requiring early antihypertensive therapy
Authors
Loading...
Supports early candesartan use for antihypertensive therapy in cerebral and myocardial ischemia; extends RCT evidence on safe neurohumoral inhibition.
Is candesartan cilexetil a safe therapeutic option for early antihypertensive therapy in patients with cerebral and myocardial ischemia?
Candesartan cilexetil is a safe therapeutic option for early antihypertensive therapy in cerebral and myocardial ischemia, without causing hypotension-related adverse events.
Schrader et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: